Roundtable Discussion: The Risk-Benefit Ratio: Why Should a Patient Choose a Gene Therapy Over Existing Treatments?

Time: 12:00 pm
day: Gene Therapy Beyond Rare Diseases Discussion Day

Details:

• Exploring the reasons that a patient may choose a gene therapy over an alternative therapeutic
• Understanding the level of safety required for a gene therapy to be approved for a non-orphan indication
• Examining current public opinion on viral therapies

Speakers:

Kali Stasi Kali Stasi is a board-certified fellowship-trained ophthalmologist and cornea surgeon. She has completed a PhD and basic research in Ophthalmic and CNS neurodegenerative & ocular Read more